Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELEVATE-PD: Real-world Study of Crexont in Parkinson's Disease
NCT06765668Phase 4Recruiting
- Sponsor
- Impax Laboratories
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in Parkinson's disease (PD), sponsored by Impax Laboratories. Started Feb 2025; status: recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06765668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765668.